Skip to content

A Study of the Effects of Probiotics in Children Grades 1-3

A Double-blind, Randomized, Placebo-controlled Study of the Effects of Probiotics in Children Grades 1-3

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00635388
Enrollment
360
Registered
2008-03-13
Start date
2008-02-29
Completion date
2008-05-31
Last updated
2009-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The primary objective of this study is to determine the appropriate study design for a full-scale claims support study to evaluate the impact of 2 probiotics on healthy days in elementary school children relative to a placebo control.

Interventions

OTHERPlacebo

oral, placebo, once/day for 12 weeks

OTHERLactobacillus (Probiotic 1)

oral, Lactobacillus, once/day for 12 weeks

OTHERLactobacillus and Bifidobacterium (Probiotic 2)

oral, Lactobacillus and Bifidobacterium, once/day for 12 weeks

Sponsors

Procter and Gamble
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 9 Years
Healthy volunteers
Yes

Inclusion criteria

* Be in good general health as reported by their parent(s)/legal guardian; * Be willing to refrain from ingesting any product that contains fermented live bacteria (other than their test product) during the study as confirmed by their parent(s)/legal guardian(s); * Be willing to continue their current dietary habits for the duration of the study as confirmed by their parent(s)/legal guardian(s)

Exclusion criteria

* Have a known hypersensitivity or allergy to any product ingredient to be ingested during the study, as reported by their parent(s)/legal guardian(s)

Design outcomes

Primary

MeasureTime frame
Number of healthy days.12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026